Clinical study of renal impairment in patients with propylthiouracil-induced small-vessel vasculitis and patients with primary ANCA-associated small-vessel vasculitis

被引:22
作者
Cao, Xiaozhi [1 ]
Lin, Weiyuan [2 ]
机构
[1] PLA, Fuzhou Gen Hosp, Dept Cardiol, Fuzhou 350025, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 2, Renal Dept Internal Med, Quanzhou 362000, Peoples R China
关键词
propylthiouracil; anti-neutrophil cytoplasmic antibody; vasculitis; renal disease; ANTIBODY-ASSOCIATED VASCULITIS; THERAPY; DISEASE;
D O I
10.3892/etm.2013.1065
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of this study was to compare renal impairment in patients with propylthiouracil (PTU)-induced small-vessel vasculitis and patients with primary anti-neutrophil cytoplasmic antibody (ANCA)-induced small-vessel vasculitis. The study compared the pathology and clinical conditions of 10 patients with PTU-associated small-vessel vasculitis and 18 patients with primary ANCA-associated small-vessel vasculitis. All patients showed manifestations of renal impairment. Compared with the primary ANCA-induced small-vessel vasculitis, patients with PTU-induced small-vessel vasculitis were mostly female (P<0.05) and deleloped the disease at a younger age (P<0.05). They had a higher positive rate of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA; P<0.05), lower 24 h proteinuria content, lower serum creatinine (P<0.05) and milder histopathological lesions (P<0.05). A number of them had gross hematuria (P<0.05). They rarely used hormone and cytotoxic drugs (P<0.05) during treatment and had a better prognosis (P<0.05). In conclusion, PTU-induced small-vessel vasculitis has a milder pathology and clinical manifestations with a better prognosis.
引用
收藏
页码:1619 / 1622
页数:4
相关论文
共 21 条
[1]   Churg-Strauss Syndrome: An Update [J].
Abril, Andy .
CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (06) :489-495
[2]   Recent Aspects of Vasculitis and Future Direction [J].
Aras, Gulfidan .
INTERNAL MEDICINE, 2011, 50 (18) :1869-1877
[3]   Treatment of Antineutrophil cytoplasmic antibody-associated vasculitis - A systematic review [J].
Bosch, Xavier ;
Guilabert, Antonio ;
Espinosa, Gerard ;
Mirapeix, Eduard .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (06) :655-669
[4]   Antineutrophil cytoplasmic antibodies [J].
Bosch, Xavier ;
Guilabert, Antonio ;
Font, Josep .
LANCET, 2006, 368 (9533) :404-418
[5]   Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis [J].
Chen, Min ;
Gao, Ying ;
Guo, Xiao-Hui ;
Zhao, Ming-Hui .
NATURE REVIEWS NEPHROLOGY, 2012, 8 (08) :476-483
[6]   Drug therapy: Antithyroid drugs [J].
Cooper, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (09) :905-917
[7]   Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update [J].
Cruz Santana, Alfredo Nicodemos ;
Woronik, Viktoria ;
Radu Halpern, Ari Stiel ;
Barbas, Carmen S. V. .
JORNAL BRASILEIRO DE PNEUMOLOGIA, 2011, 37 (06) :809-816
[8]   Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement [J].
de Lind van Wijngaarden, Robert A. F. ;
Hauer, Herbert A. ;
Wolterbeek, Ron ;
Jayne, David R. W. ;
Gaskin, Gill ;
Rasmussen, Niels ;
Noel, Laure-Helene ;
Ferrario, Franco ;
Waldherr, Rudiger ;
Hagen, E. Christiaan ;
Bruijn, Jan A. ;
Bajema, Ingeborg M. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (08) :2264-2274
[9]  
Erwig LP, 2010, NETH J MED, V68, P62
[10]   Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis [J].
Gao, Ying ;
Zhao, Ming-Hui .
NEPHROLOGY, 2009, 14 (01) :33-41